Global SNP Genotyping and Analysis Industry

Global SNP Genotyping and Analysis Market to Reach $30. 7 Billion by 2027. Amid the COVID-19 crisis, the global market for SNP Genotyping and Analysis estimated at US$9. 2 Billion in the year 2020, is projected to reach a revised size of US$30.

New York, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global SNP Genotyping and Analysis Industry" - https://www.reportlinker.com/p05961149/?utm_source=GNW
7 Billion by 2027, growing at a CAGR of 18.8% over the analysis period 2020-2027. SNP Genotyping by Microarrays and GeneChips, one of the segments analyzed in the report, is projected to record a 22.5% CAGR and reach US$11.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Taqman Allelic Discrimination segment is readjusted to a revised 18.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 18.2% CAGR

The SNP Genotyping and Analysis market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2027 trailing a CAGR of 18.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.1% and 15.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

SNP Pyrosequencing Segment to Record 17.6% CAGR

In the global SNP Pyrosequencing segment, USA, Canada, Japan, China and Europe will drive the 17.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.6 Billion in the year 2020 will reach a projected size of US$4.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2027.We bring years of research experience to this 8th edition of our report. The 186-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Affymetrix, Inc.

• F. Hoffmann-La Roche AG

• Fluidigm Corporation

• Illumina, Inc.

• Life Technologies Corporation

• Sequenom, Inc.

Read the full report: https://www.reportlinker.com/p05961149/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
SNP Genotyping and Analysis Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for SNP Genotyping and
Analysis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027

Table 2: World Historic Review for SNP Genotyping and Analysis
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 3: World 15-Year Perspective for SNP Genotyping and
Analysis by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for SNP Genotyping by
Microarrays and GeneChips by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 5: World Historic Review for SNP Genotyping by
Microarrays and GeneChips by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 6: World 15-Year Perspective for SNP Genotyping by
Microarrays and GeneChips by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Taqman Allelic
Discrimination by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 8: World Historic Review for Taqman Allelic
Discrimination by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 9: World 15-Year Perspective for Taqman Allelic
Discrimination by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for SNP
Pyrosequencing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 11: World Historic Review for SNP Pyrosequencing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 12: World 15-Year Perspective for SNP Pyrosequencing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Applied
Biosciences SNPlex by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 14: World Historic Review for Applied Biosciences SNPlex
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 15: World 15-Year Perspective for Applied Biosciences
SNPlex by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Sequenom
MassARRAY MALDI-TOF by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 17: World Historic Review for Sequenom MassARRAY
MALDI-TOF by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 18: World 15-Year Perspective for Sequenom MassARRAY
MALDI-TOF by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Diagnostic
Research by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027

Table 20: World Historic Review for Diagnostic Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 21: World 15-Year Perspective for Diagnostic Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Pharmaceuticals
and Pharmacogenomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 23: World Historic Review for Pharmaceuticals and
Pharmacogenomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 24: World 15-Year Perspective for Pharmaceuticals and
Pharmacogenomics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Agricultural
Biotechnology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027

Table 26: World Historic Review for Agricultural Biotechnology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 27: World 15-Year Perspective for Agricultural
Biotechnology by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Breeding and
Animal Livestock by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 29: World Historic Review for Breeding and Animal
Livestock by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 30: World 15-Year Perspective for Breeding and Animal
Livestock by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US SNP Genotyping and Analysis Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 31: USA Current & Future Analysis for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 32: USA Historic Review for SNP Genotyping and Analysis
by Technology - SNP Genotyping by Microarrays and GeneChips,
Taqman Allelic Discrimination, SNP Pyrosequencing, Applied
Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 33: USA 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 34: USA Current & Future Analysis for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027

Table 35: USA Historic Review for SNP Genotyping and Analysis
by Application - Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 36: USA 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for SNP Genotyping
and Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 38: Canada Historic Review for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 39: Canada 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 40: Canada Current & Future Analysis for SNP Genotyping
and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 41: Canada Historic Review for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 42: Canada 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

JAPAN
Table 43: Japan Current & Future Analysis for SNP Genotyping
and Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 44: Japan Historic Review for SNP Genotyping and Analysis
by Technology - SNP Genotyping by Microarrays and GeneChips,
Taqman Allelic Discrimination, SNP Pyrosequencing, Applied
Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 45: Japan 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 46: Japan Current & Future Analysis for SNP Genotyping
and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 47: Japan Historic Review for SNP Genotyping and Analysis
by Application - Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 48: Japan 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

CHINA
Table 49: China Current & Future Analysis for SNP Genotyping
and Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 50: China Historic Review for SNP Genotyping and Analysis
by Technology - SNP Genotyping by Microarrays and GeneChips,
Taqman Allelic Discrimination, SNP Pyrosequencing, Applied
Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 51: China 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 52: China Current & Future Analysis for SNP Genotyping
and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 53: China Historic Review for SNP Genotyping and Analysis
by Application - Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 54: China 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European SNP Genotyping and Analysis Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 55: Europe Current & Future Analysis for SNP Genotyping
and Analysis by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027

Table 56: Europe Historic Review for SNP Genotyping and
Analysis by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 57: Europe 15-Year Perspective for SNP Genotyping and
Analysis by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for SNP Genotyping
and Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 59: Europe Historic Review for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 60: Europe 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 61: Europe Current & Future Analysis for SNP Genotyping
and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 62: Europe Historic Review for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 63: Europe 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

FRANCE
Table 64: France Current & Future Analysis for SNP Genotyping
and Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 65: France Historic Review for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 66: France 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 67: France Current & Future Analysis for SNP Genotyping
and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 68: France Historic Review for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 69: France 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

GERMANY
Table 70: Germany Current & Future Analysis for SNP Genotyping
and Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 71: Germany Historic Review for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 72: Germany 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 73: Germany Current & Future Analysis for SNP Genotyping
and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 74: Germany Historic Review for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 75: Germany 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

ITALY
Table 76: Italy Current & Future Analysis for SNP Genotyping
and Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 77: Italy Historic Review for SNP Genotyping and Analysis
by Technology - SNP Genotyping by Microarrays and GeneChips,
Taqman Allelic Discrimination, SNP Pyrosequencing, Applied
Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 78: Italy 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 79: Italy Current & Future Analysis for SNP Genotyping
and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 80: Italy Historic Review for SNP Genotyping and Analysis
by Application - Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 81: Italy 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 82: UK Current & Future Analysis for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 83: UK Historic Review for SNP Genotyping and Analysis by
Technology - SNP Genotyping by Microarrays and GeneChips,
Taqman Allelic Discrimination, SNP Pyrosequencing, Applied
Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 84: UK 15-Year Perspective for SNP Genotyping and
Analysis by Technology - Percentage Breakdown of Value Sales
for SNP Genotyping by Microarrays and GeneChips, Taqman Allelic
Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex
and Sequenom MassARRAY MALDI-TOF for the Years 2012, 2020 &
2027

Table 85: UK Current & Future Analysis for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027

Table 86: UK Historic Review for SNP Genotyping and Analysis by
Application - Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 87: UK 15-Year Perspective for SNP Genotyping and
Analysis by Application - Percentage Breakdown of Value Sales
for Diagnostic Research, Pharmaceuticals and Pharmacogenomics,
Agricultural Biotechnology and Breeding and Animal Livestock
for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 88: Rest of Europe Current & Future Analysis for SNP
Genotyping and Analysis by Technology - SNP Genotyping by
Microarrays and GeneChips, Taqman Allelic Discrimination, SNP
Pyrosequencing, Applied Biosciences SNPlex and Sequenom
MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027

Table 89: Rest of Europe Historic Review for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 90: Rest of Europe 15-Year Perspective for SNP Genotyping
and Analysis by Technology - Percentage Breakdown of Value
Sales for SNP Genotyping by Microarrays and GeneChips, Taqman
Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences
SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2012,
2020 & 2027

Table 91: Rest of Europe Current & Future Analysis for SNP
Genotyping and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 92: Rest of Europe Historic Review for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 93: Rest of Europe 15-Year Perspective for SNP Genotyping
and Analysis by Application - Percentage Breakdown of Value
Sales for Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 94: Asia-Pacific Current & Future Analysis for SNP
Genotyping and Analysis by Technology - SNP Genotyping by
Microarrays and GeneChips, Taqman Allelic Discrimination, SNP
Pyrosequencing, Applied Biosciences SNPlex and Sequenom
MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027

Table 95: Asia-Pacific Historic Review for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 96: Asia-Pacific 15-Year Perspective for SNP Genotyping
and Analysis by Technology - Percentage Breakdown of Value
Sales for SNP Genotyping by Microarrays and GeneChips, Taqman
Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences
SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2012,
2020 & 2027

Table 97: Asia-Pacific Current & Future Analysis for SNP
Genotyping and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 98: Asia-Pacific Historic Review for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 99: Asia-Pacific 15-Year Perspective for SNP Genotyping
and Analysis by Application - Percentage Breakdown of Value
Sales for Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock for the Years 2012, 2020 & 2027

REST OF WORLD
Table 100: Rest of World Current & Future Analysis for SNP
Genotyping and Analysis by Technology - SNP Genotyping by
Microarrays and GeneChips, Taqman Allelic Discrimination, SNP
Pyrosequencing, Applied Biosciences SNPlex and Sequenom
MassARRAY MALDI-TOF - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027

Table 101: Rest of World Historic Review for SNP Genotyping and
Analysis by Technology - SNP Genotyping by Microarrays and
GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing,
Applied Biosciences SNPlex and Sequenom MassARRAY MALDI-TOF
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 102: Rest of World 15-Year Perspective for SNP Genotyping
and Analysis by Technology - Percentage Breakdown of Value
Sales for SNP Genotyping by Microarrays and GeneChips, Taqman
Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences
SNPlex and Sequenom MassARRAY MALDI-TOF for the Years 2012,
2020 & 2027

Table 103: Rest of World Current & Future Analysis for SNP
Genotyping and Analysis by Application - Diagnostic Research,
Pharmaceuticals and Pharmacogenomics, Agricultural
Biotechnology and Breeding and Animal Livestock - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 104: Rest of World Historic Review for SNP Genotyping and
Analysis by Application - Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology and Breeding
and Animal Livestock Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 105: Rest of World 15-Year Perspective for SNP Genotyping
and Analysis by Application - Percentage Breakdown of Value
Sales for Diagnostic Research, Pharmaceuticals and
Pharmacogenomics, Agricultural Biotechnology and Breeding and
Animal Livestock for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 42
Read the full report: https://www.reportlinker.com/p05961149/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001